| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 105.849 | 683.546 | 474.341 | 47.032 |
| Total Income - EUR | - | - | - | - | - | - | 105.849 | 685.346 | 484.762 | 47.492 |
| Total Expenses - EUR | - | - | - | - | - | - | 0 | 8.382 | 242.541 | 44.940 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 105.849 | 676.964 | 242.221 | 2.552 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 102.737 | 670.674 | 238.573 | 2.105 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ambalaris Farma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 105.889 | 1.088.695 | 788.038 | 690.145 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 5.036 |
| Receivables | - | - | - | - | - | - | 105.849 | 829.529 | 86.230 | 136.177 |
| Cash | - | - | - | - | - | - | 40 | 259.166 | 701.808 | 548.933 |
| Shareholders Funds | - | - | - | - | - | - | 102.778 | 670.714 | 473.148 | 70.543 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 3.112 | 417.980 | 314.890 | 619.602 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Ambalaris Farma S.r.l.